Disodium etidronate was the first bisphosphonate to be used clinically in the management of Paget's disease.
Adverse effects include:
There have now been developed second- and third- generation bisphosphonates.
The summary of product characteristics should be consulted before prescribing this drug.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.